$GANX
Gain Therapeutics, Inc.

2021 Form 10-K Financial Statement

#000155837022004363 Filed on March 25, 2022

View on sec.gov

Income Statement

Concept 2021 2020 Q4 2020
Revenue $165.0K $28.88K
YoY Change 471.29% -27.8%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $6.827M $1.250M
YoY Change 446.16% 123.21%
% of Gross Profit
Research & Development $7.164M $2.259M
YoY Change 217.11% 42.09%
% of Gross Profit
Depreciation & Amortization $15.48K $9.592K
YoY Change 61.43%
% of Gross Profit
Operating Expenses $13.99M $3.508M
YoY Change 298.8% 63.94%
Operating Profit -$13.83M -$3.479M
YoY Change 297.37%
Interest Expense -$60.42K -$90.00K
YoY Change -32.87% 0.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$13.89M -$3.572M
YoY Change 288.73% 63.12%
Income Tax $4.008K $5.386K
% Of Pretax Income
Net Earnings -$13.89M -$3.578M
YoY Change 288.26% 63.36%
Net Earnings / Revenue -8418.86% -12387.67%
Basic Earnings Per Share -$1.37 -$1.33
Diluted Earnings Per Share -$1.37 -$1.33
COMMON SHARES
Basic Shares Outstanding 10.17M 2.681M
Diluted Shares Outstanding 10.17M 2.681M

Balance Sheet

Concept 2021 2020 Q4 2020
SHORT-TERM ASSETS
Cash & Short-Term Investments $36.88M $7.490M
YoY Change 392.4% 2396.67%
Cash & Equivalents $33.62M $7.493M $7.490M
Short-Term Investments $33.62M
Other Short-Term Assets $645.9K $1.430M
YoY Change -54.83% 1687.5%
Inventory
Prepaid Expenses
Receivables $0.00 $8.548K $10.00K
Other Receivables $195.5K $60.00K
Total Short-Term Assets $37.72M $8.988M $8.990M
YoY Change 319.6% 1990.7%
LONG-TERM ASSETS
Property, Plant & Equipment $1.210M $29.63K $550.0K
YoY Change 119.93% 150.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $53.39K $51.67K $60.00K
YoY Change -11.02% 500.0%
Total Long-Term Assets $1.263M $616.5K $610.0K
YoY Change 107.05% 165.22%
TOTAL ASSETS
Total Short-Term Assets $37.72M $8.988M $8.990M
Total Long-Term Assets $1.263M $616.5K $610.0K
Total Assets $38.99M $9.604M $9.600M
YoY Change 306.09% 1354.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $560.5K $961.5K $960.0K
YoY Change -41.62% 540.0%
Accrued Expenses $1.366M $379.3K $800.0K
YoY Change 70.79% 158.06%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $103.8K $22.63K $20.00K
YoY Change 419.15%
Total Short-Term Liabilities $2.553M $2.115M $2.110M
YoY Change 20.97% 139.77%
LONG-TERM LIABILITIES
Long-Term Debt $590.5K $715.7K $720.0K
YoY Change -17.99%
Other Long-Term Liabilities $1.025M $570.0K
YoY Change 79.74% 147.83%
Total Long-Term Liabilities $1.615M $1.288M $1.290M
YoY Change 25.19% 460.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.553M $2.115M $2.110M
Total Long-Term Liabilities $1.615M $1.288M $1.290M
Total Liabilities $4.168M $3.402M $3.400M
YoY Change 22.57% 206.31%
SHAREHOLDERS EQUITY
Retained Earnings -$3.457M
YoY Change
Common Stock $354.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $34.82M $6.202M $6.200M
YoY Change
Total Liabilities & Shareholders Equity $38.99M $9.604M $9.600M
YoY Change 306.09% 1354.55%

Cashflow Statement

Concept 2021 2020 Q4 2020
OPERATING ACTIVITIES
Net Income -$13.89M -$3.578M
YoY Change 288.26% 63.36%
Depreciation, Depletion And Amortization $15.48K $9.592K
YoY Change 61.43%
Cash From Operating Activities -$12.37M -$3.240M
YoY Change 281.63% 73.27%
INVESTING ACTIVITIES
Capital Expenditures $94.21K $20.83K
YoY Change 352.38% -308.26%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$94.21K -$20.83K
YoY Change 352.38% 108.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 41.77M 10.49M
YoY Change 298.27% 499.25%
NET CHANGE
Cash From Operating Activities -12.37M -3.240M
Cash From Investing Activities -94.21K -20.83K
Cash From Financing Activities 41.77M 10.49M
Net Change In Cash 29.41M 7.191M
YoY Change 308.97% -5631.22%
FREE CASH FLOW
Cash From Operating Activities -$12.37M -$3.240M
Capital Expenditures $94.21K $20.83K
Free Cash Flow -$12.46M -$3.261M
YoY Change 282.08% 75.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
198994
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.37
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.33
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10165404
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2681408
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001819411
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 us-gaap Interest Expense Debt
InterestExpenseDebt
0
CY2020 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2021 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2021Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
1.1353521
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3543163
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11883368
CY2021Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
1.1353521
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3543163
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11883368
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4022736
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity File Number
EntityFileNumber
001-40237
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Entity Registrant Name
EntityRegistrantName
GAIN THERAPEUTICS, INC
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-1726310
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
4800 Montgomery Lane
CY2021 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 220
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Bethesda
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20814
CY2021 dei City Area Code
CityAreaCode
301
CY2021 dei Local Phone Number
LocalPhoneNumber
500-1556
CY2021 dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
CY2021 dei Trading Symbol
TradingSymbol
GANX
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
true
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
118700000
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11883368
CY2021 dei Auditor Firm
AuditorFirmId
1460
CY2021 dei Auditor Name
AuditorName
Ernst & Young AG
CY2021 dei Auditor Location
AuditorLocation
Lugano, Switzerland
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36880673
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7492910
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
11371
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8548
CY2021Q4 us-gaap Deferred Income Taxes And Other Tax Receivable Current
DeferredIncomeTaxesAndOtherTaxReceivableCurrent
113586
CY2020Q4 us-gaap Deferred Income Taxes And Other Tax Receivable Current
DeferredIncomeTaxesAndOtherTaxReceivableCurrent
58017
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
727785
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
198994
CY2020Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
1217988
CY2021Q4 us-gaap Assets Current
AssetsCurrent
37722044
CY2020Q4 us-gaap Assets Current
AssetsCurrent
8987828
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
105986
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29633
CY2021Q4 ganx Capitalized Computer Software For Internal Use
CapitalizedComputerSoftwareForInternalUse
202609
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
901042
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
523080
CY2021Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
31279
CY2021Q4 ganx Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
22111
CY2020Q4 ganx Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
63817
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1263027
CY2020Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
616530
CY2021Q4 us-gaap Assets
Assets
38985071
CY2021Q4 us-gaap Deferred Income Current
DeferredIncomeCurrent
266504
CY2020Q4 us-gaap Assets
Assets
9604358
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
560479
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
961516
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
219137
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1249126
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
122756
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1402600
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
768450
CY2020Q4 us-gaap Deferred Income Current
DeferredIncomeCurrent
239483
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
103826
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
22626
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2552546
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2114831
CY2021Q4 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
329458
CY2020Q4 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
171558
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
695053
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
400324
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
590468
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
715656
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1614979
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1287538
CY2021Q4 us-gaap Liabilities
Liabilities
4167525
CY2020Q4 us-gaap Liabilities
Liabilities
3402369
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11883368
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3543163
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1189
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
354
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
55832461
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
13388771
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-90645
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-152698
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7034853
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3457171
CY2021Q4 ganx Income Loss For Period
IncomeLossForPeriod
-13890606
CY2020Q4 ganx Income Loss For Period
IncomeLossForPeriod
-3577682
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
34817546
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
6201989
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
38985071
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9604358
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
133928
CY2021 us-gaap Sublease Income
SubleaseIncome
31066
CY2020 us-gaap Sublease Income
SubleaseIncome
28881
CY2021 us-gaap Revenues
Revenues
164994
CY2020 us-gaap Revenues
Revenues
28881
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7164229
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2259204
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6826938
CY2021 us-gaap Operating Expenses
OperatingExpenses
13991167
CY2020 us-gaap Operating Expenses
OperatingExpenses
3508330
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-13826173
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-3479449
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
12495
CY2020 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
3637
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-3577682
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.37
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-72920
CY2020 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-96484
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13886598
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3572296
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4008
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5386
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-13890606
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.33
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10165404
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2681408
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-13890606
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-3577682
CY2021 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
101780
CY2020 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
36218
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
163833
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-35317
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
62053
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-71535
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13828553
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3649217
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
6201989
CY2021 ganx Issuance Of Common Stock In Ipo Net Of Issuance Costs
IssuanceOfCommonStockInIpoNetOfIssuanceCosts
40558522
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
12217
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
839371
CY2021 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1034000
CY2021 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
101780
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
163833
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-13890606
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
34817546
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-449856
CY2020 ganx Issuance Of Series Preferred Stock Net Of Issuance Cost
IssuanceOfSeriesPreferredStockNetOfIssuanceCost
1091345
CY2020 ganx Issuance Of Series B Preferred Stock Net Of Issuance Cost
IssuanceOfSeriesBPreferredStockNetOfIssuanceCost
8714013
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
177
CY2020 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
413887
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
81640
CY2020 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
36218
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-35317
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-3577682
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
6201989
CY2021 us-gaap Profit Loss
ProfitLoss
-13890606
CY2020 us-gaap Profit Loss
ProfitLoss
-3577682
CY2021 us-gaap Depreciation
Depreciation
15484
CY2020 us-gaap Depreciation
Depreciation
9592
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
839371
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
81640
CY2021 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
1034000
CY2021 ganx Capitalized Computer Software Adjustment
CapitalizedComputerSoftwareAdjustment
34135
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8264
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
196
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
534502
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
117704
CY2021 us-gaap Pension Expense Reversal Of Expense Noncash
PensionExpenseReversalOfExpenseNoncash
55326
CY2020 us-gaap Pension Expense Reversal Of Expense Noncash
PensionExpenseReversalOfExpenseNoncash
8709
CY2021 ganx Increase Decrease In Value Added Tax Credits
IncreaseDecreaseInValueAddedTaxCredits
71618
CY2020 ganx Increase Decrease In Value Added Tax Credits
IncreaseDecreaseInValueAddedTaxCredits
21454
CY2021 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-33979
CY2020 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
63095
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-521394
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
395543
CY2021 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
665460
CY2020 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
173725
CY2021 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
34701
CY2020 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-129315
CY2021 ganx Increase Decrease In Operating Assets And Liabilities
IncreaseDecreaseInOperatingAssetsAndLiabilities
329784
CY2020 ganx Increase Decrease In Operating Assets And Liabilities
IncreaseDecreaseInOperatingAssetsAndLiabilities
-246213
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12365670
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3240237
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
94212
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20826
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-94212
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-20826
CY2020 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
738282
CY2020 ganx Proceeds From Issuance Of Series A.Preferred Stock Net Of Issuance Costs
ProceedsFromIssuanceOfSeriesA.PreferredStockNetOfIssuanceCosts
1091345
CY2020 ganx Proceeds From Issuance Of Series B Preferred Stock Net Of Issuance Costs
ProceedsFromIssuanceOfSeriesBPreferredStockNetOfIssuanceCosts
9127902
CY2021 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
42629998
CY2020 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
177
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
853488
CY2020 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
470745
CY2021 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
21951
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
12216
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
41766775
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10486961
CY2021 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
100778
CY2020 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-35317
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
29407671
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7190581
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7504281
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
313700
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36911952
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7504281
CY2020Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
10
CY2021Q1 ganx Preferred Stock To Common Stock Conversion Ratio
PreferredStockToCommonStockConversionRatio
1
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
165156
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
1323
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt;">The preparation of our consolidated financial statements in conformity with US GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting periods. On an ongoing basis, we evaluate our estimates judgments and, assumptions including those related to recognition of grant funds, accrued expenses, defined benefit pension liability, warrants and stock-based compensation. These estimates and assumptions are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances, the results of which form the </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">basis for making judgments about the carrying values of assets and liabilities and the recording of expenses that are not readily apparent from other sources. Actual results may differ materially and adversely from these estimates. Changes in estimates are recorded in the period in which they become known. To the extent that material differences arise between the estimates and actual results, the Company’s future results of operations will be affected. The COVID-19 pandemic did not have a significant impact on the Company’s estimates.</p>
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Concentrations of credit risk</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company has no significant off-balance sheet risk, such as foreign exchange contracts, option contracts, or other foreign hedging arrangements. Financial instruments that may expose the Company to concentrations of credit risk consist primarily of cash, cash equivalents which are deposited in accredited financial institutions in excess of federally insured limits. The Company deposits its cash and cash equivalents in financial institutions that it believes have high credit quality and has not experienced any losses on such accounts and does not believe it is exposed to any unusual credit risk beyond the normal credit risk associated with commercial banking relationships.</p>
CY2021Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
0
CY2020Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1217988
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
202609
CY2020Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
0
CY2021 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
168474
CY2020 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
34135
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2021Q4 ganx Uncertain Tax Positions Recognized
UncertainTaxPositionsRecognized
0
CY2021Q4 us-gaap Deferred Income Taxes And Other Tax Receivable Current
DeferredIncomeTaxesAndOtherTaxReceivableCurrent
113586
CY2020Q4 us-gaap Deferred Income Taxes And Other Tax Receivable Current
DeferredIncomeTaxesAndOtherTaxReceivableCurrent
58017
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
498252
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36880673
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7492910
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
31279
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
11371
CY2021Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
81862
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
147671
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
727785
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
198994
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
134375
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
42538
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
28389
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12905
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
105986
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29633
CY2020 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
0
CY2021 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
0
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15484
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9592
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
901042
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
523080
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
219137
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
122756
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
695053
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
400324
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0186
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0361
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
191329
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
121800
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
237926
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
245685
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
227115
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
167526
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
58738
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
936990
CY2021Q4 ganx Adjustment To Reconcile Operating Lease Liabilities Amounts Representing Interest Or Imputed Interest
AdjustmentToReconcileOperatingLeaseLiabilitiesAmountsRepresentingInterestOrImputedInterest
22800
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
914190
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
560479
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
961516
CY2021Q4 ganx Expenses Or Charges Due For Early Extinguishment Of Debt
ExpensesOrChargesDueForEarlyExtinguishmentOfDebt
0
CY2021Q4 ganx Payable For Social Securities Current
PayableForSocialSecuritiesCurrent
255068
CY2020Q4 ganx Payable For Social Securities Current
PayableForSocialSecuritiesCurrent
88334
CY2021Q4 ganx Accrued Payroll Current
AccruedPayrollCurrent
465382
CY2020Q4 ganx Accrued Payroll Current
AccruedPayrollCurrent
294469
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
681770
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
379270
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
380
CY2020Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
1070
CY2020Q4 ganx Deposits Current
DepositsCurrent
5307
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1402600
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
768450
CY2021Q4 us-gaap Deferred Income Current
DeferredIncomeCurrent
266504
CY2020Q4 us-gaap Deferred Income Current
DeferredIncomeCurrent
239483
CY2021Q4 us-gaap Deferred Credits And Other Liabilities Current
DeferredCreditsAndOtherLiabilitiesCurrent
1669104
CY2020Q4 us-gaap Deferred Credits And Other Liabilities Current
DeferredCreditsAndOtherLiabilitiesCurrent
1007933
CY2021 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
3243
CY2020 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0
CY2021Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
0
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
694294
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
103826
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
87806
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
87806
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
87806
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
87806
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
239244
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11883368
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3543163
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4022736
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 ganx Preferred Stock To Common Stock Conversion Ratio
PreferredStockToCommonStockConversionRatio
1
CY2021Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
1
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
1111942
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-7601640
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-623667
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-6284958
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-2948629
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13886598
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3572296
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
4008
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
5386
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
4008
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
5386
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4008
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5386
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
18239792
CY2020Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
6608396
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
2243668
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
1677610
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
146451
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
253439
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
22465
CY2021Q4 ganx Deferred Tax Assets Fmw Warrant
DeferredTaxAssetsFmwWarrant
284531
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
4010
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
4463258
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1280858
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1137
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
2682
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1137
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2682
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4462121
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1278176
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0652
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0652
CY2021 ganx Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.0010
CY2020 ganx Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
0.0000
CY2021 ganx Effective Income Tax Rate Reconciliation Provision To Return
EffectiveIncomeTaxRateReconciliationProvisionToReturn
0.0013
CY2020 ganx Effective Income Tax Rate Reconciliation Provision To Return
EffectiveIncomeTaxRateReconciliationProvisionToReturn
0.0000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.0003
CY2020 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.0015
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.2752
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.2737
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0000
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0000
CY2020Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2020 ganx Expense For Interest And Penalties Related To Uncertain Tax Position Recognized In Statement Of Operations
ExpenseForInterestAndPenaltiesRelatedToUncertainTaxPositionRecognizedInStatementOfOperations
0
CY2021 ganx Expense For Interest And Penalties Related To Uncertain Tax Position Recognized In Statement Of Operations
ExpenseForInterestAndPenaltiesRelatedToUncertainTaxPositionRecognizedInStatementOfOperations
0
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.33

Files In Submission

Name View Source Status
0001558370-22-004363-index-headers.html Edgar Link pending
0001558370-22-004363-index.html Edgar Link pending
0001558370-22-004363.txt Edgar Link pending
0001558370-22-004363-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
ganx-20211231.xsd Edgar Link pending
ganx-20211231x10k.htm Edgar Link pending
ganx-20211231x10k001.jpg Edgar Link pending
ganx-20211231x10k002.jpg Edgar Link pending
ganx-20211231x10k003.jpg Edgar Link pending
ganx-20211231x10k004.jpg Edgar Link pending
ganx-20211231x10k005.jpg Edgar Link pending
ganx-20211231x10k006.jpg Edgar Link pending
ganx-20211231x10k007.jpg Edgar Link pending
ganx-20211231x10k008.jpg Edgar Link pending
ganx-20211231x10k009.jpg Edgar Link pending
ganx-20211231x10k010.jpg Edgar Link pending
ganx-20211231x10k_htm.xml Edgar Link completed
ganx-20211231xex10d8.htm Edgar Link pending
ganx-20211231xex10d8001.jpg Edgar Link pending
ganx-20211231xex10d8003.jpg Edgar Link pending
ganx-20211231xex10d8004.jpg Edgar Link pending
ganx-20211231xex10d8005.jpg Edgar Link pending
ganx-20211231xex10d8006.jpg Edgar Link pending
ganx-20211231xex10d8007.jpg Edgar Link pending
ganx-20211231xex10d8008.jpg Edgar Link pending
ganx-20211231xex10d8009.jpg Edgar Link pending
ganx-20211231xex10d8011.jpg Edgar Link pending
ganx-20211231xex23d1.htm Edgar Link pending
ganx-20211231xex23d1001.jpg Edgar Link pending
ganx-20211231xex31d1.htm Edgar Link pending
ganx-20211231xex31d2.htm Edgar Link pending
ganx-20211231xex32d1.htm Edgar Link pending
ganx-20211231xex4d1.htm Edgar Link pending
ganx-20211231_cal.xml Edgar Link unprocessable
ganx-20211231_def.xml Edgar Link unprocessable
ganx-20211231_lab.xml Edgar Link unprocessable
ganx-20211231_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending